Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation

BMC Immunology

Volumn 15, Issue 1, 2014, Pages

  Gregorini, Marilena ^a   Bosio, Francesca ^a   Rocca, Chiara ^a   Corradetti, Valeria ^a   Valsania, Teresa ^a   Pattonieri, Eleonora Francesca ^a   Esposito, Pasquale ^b   Bedino, Giulia ^a   Collesi, Chiara ^c   Libetta, Carmelo ^a   Frassoni, Francesco ^d   Dal Canton, Antonio ^a   Rampino, Teresa ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Acute kidney rejection; Experimental model; Hepatocyte growth factor; Macrophage stimulating protein; Mesenchymal stromal cells; Scatter factors

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE ACTIVATING FACTOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, RAT; MACROPHAGE STIMULATING PROTEIN; MESSENGER RNA; ONCOPROTEIN; PROTEIN TYROSINE KINASE; RON PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; EXPERIMENTAL MODEL; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; MACROPHAGE; MESENCHYMAL STROMA CELL; MONOCYTE; NONHUMAN; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE; RENAL ARTERY; REPERFUSION; TH1 CELL; ALLOGRAFT; ANIMAL; BLOOD; CELL PROLIFERATION; FISCHER 344 RAT; GENETICS; KIDNEY TUBULE; METABOLISM; NECROSIS; PATHOLOGY;

ALLOGRAFTS; ANIMALS; CELL PROLIFERATION; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; HEPATOCYTE GROWTH FACTOR; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MESENCHYMAL STROMAL CELLS; MONOCYTES; NECROSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, INBRED F344; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, MESSENGER;

EID: 84907952454     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/s12865-014-0044-1     Document Type: Article

References (63)

1. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006, 8:315-317.
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 2006, 284:43-147.
3. Keating A: Mesenchymal stromal cells. Curr Opin in Hematol 2006, 13:419-425.
4. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O: HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003, 31:890-896.
5. Aggarwal S, Pittenger MF: Human mesenchymal stem cells modulate allogenic immune cell response. Blood 2005, 105:1815-1822.
6. Le Blanc K, Ringdén O: Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007, 262:509-525.
7. Comoli P, Ginevri F, Maccario R, Avanzini MA, Marconi M, Groff A, Cometa A, Cioni M, Porretti L, Barberi W, Frassoni F, Locatelli F: Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol Dial Transplant 2008, 23:1196-1202.
8. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A: Human mesenchymal stem cells modulate B-cell functions. Blood 2006, 107:367-372.
9. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L: Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamina 2,3-dioxygenase and prostaglandin E2. Blood 2008, 111:1327-1333.
10. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringdén O: Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003, 57:11-20.
11. Yi T, Song SU: Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch Pharm Res 2012, 35:213-221.
12. Prevosto C, Zancolli M, Carnevali P, Zocchi MR, Poggi A: Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 2007, 92:881-888.
13. Casiraghi F, Perico N, Remuzzi G: Mesenchymal stromal cells to promote solid organ transplantation tolerance. Curr Opin Organ Transplant 2013, 18:51-58.
14. Duffy MM, Ritter T, Ceredig R, Griffin MD: Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther 2011, 2:34.
15. De Martino M, Zonta S, Rampino T, Gregorini M, Frassoni F, Piotti G, Bedino G, Cobianchi L, Dal Canton A, Dionigi P, Alessiani M: Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation. Transplant Proc 2010, 42:1331-1335.
16. Casiraghi F, Azzollini N, Todeschini M, Cavinato RA, Cassis P, Solini S, Rota C, Morigi M, Introna M, Maranta R, Perico N, Remuzzi G, Noris M: Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation. Am J Transplant 2012, 12:2373-2383.
17. Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, Rottoli D, Angioletti S, Benigni A, Perico N, Alison M, Remuzzi G: Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004, 15:1794-1804.
18. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G: Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 2004, 14:1035-1041.
19. Lange C, Tögel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, Westenfelder C: Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure. Kidney Int 2005, 68:1613-1617.
20. Bussolati B, Hauser PV, Carvalhosa R, Camussi G: Contribution of stem cells to kidney repair. Curr Stem Cell Res Ther 2009, 4:2-8.
21. Chhabra P, Brayman KL: The use of stem cells in kidney disease. Curr Opin Organ Transplant 2009, 14:72-78.
22. Tögel F, Cohen A, Zhang P, Yang Y, Hu Z, Westenfelder C: Autologous and allogeneic marrow stromal cells are safe and effective for treatment of acute kidney injury. Stem Cells Dev 2009, 18:475-485.
23. Choi S, Park M, Kim J, Hwang S, Park S, Lee Y: The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 2009, 18:521-529.
24. Doorn J, Moll G, Le Blanc K, van Blitterswijk C, de Boer J: Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng Part B Rev 2012, 18:101-115.
25. English K: Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol 2013, 91:19-26.
26. Casiraghi F, Noris M, Remuzzi G: Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation. Curr Opin Organ Transplant 2010, 24:731-737.
27. Abumaree M, Al Jumah M, Pace RA, Kalionis B: Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev 2012, 8:375-392.
28. Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C: Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005, 289:F31-F42.
29. Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG: Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 2007, 18:2486-2496.
30. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G: Mesenchymal stem cell-derived microvescicles protect against acute tubular injury. J Am Soc Nephrol 2009, 20:1053-1067.
31. Camussi G, Deregibus MC, Tetta C: Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvescicle-mediated transfer of genetic information. Curr Opin Nephrol Hypertens 2010, 19:7-12.
32. Soleymaninejadian E, Pramanik K, Samadian E: Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol 2012, 67:1-8.
33. Rampino T, Collesi C, Gregorini M, Maggio M, Soccio G, Guallini P, Guallini P, Dal Canton A: Macrophage-stimulating protein is produced by tubular cells and activates mesangial cells. J Am Soc Nephrol 2002, 13:649-657.
34. Cantley LG, Barros EJ, Gandhi M, Rauchman M, Nigam SK: Regulation of mitogenesis, motogenesis, and tubulogenesis by hepatocyte growth factor in renal collecting duct cells. Am J Physiol 1994, 267:F271-F280.
35. Liu Y: Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens 2002, 11:23-30.
36. Rampino T, Soccio G, Gregorini M, Guidetti C, Marasà M, Maggio M, Panichi V, Migliori M, Libetta C, Dal Canton A: Neutralization of macrophage-stimulating protein ameliorates renal injury in anti-thy 1 glomerulonephritis. J Am Soc Nephrol 2007, 18:1486-1496.
37. Cantaluppi V, Biancone L, Romanazzi GM, Figliolini F, Beltramo S, Galimi F, Camboni MG, Deriu E, Conaldi P, Bottelli A, Orlandi V, Herrera MB, Pacitti A, Segoloni GP, Camussi G: Macrophage stimulating protein may promote tubular regeneration after acute injury. J Am Soc Nephrol 2008, 19:1904-1918.
38. Homsi E, Janino P, Amano M, Saraiva Camara NO: Endogenous hepatocyte growth factor attenuates inflammatory response in glycerol-induced acute kidney injury. Am J Nephrol 2009, 29:283-291.
39. Mori T, Shimizu A, Masuda Y, Fukuda Y, Yamanaka N: Hepatocyte growth factor-stimulating endothelial cell growth and accelerating glomerular capillary repair in experimental progressive glomerulonephritis. Nephron Exp Nephrol 2003, 94:e44-e54.
40. Takada S, Namiki M, Takahara S, Matsumiya K, Kondoh N, Kokado Y, Matsumoto K, Nakamura T, Okuyama A: Serum HGF levels in acute renal rejection after living related renal transplantation. Transpl Int 1996, 9:151-154.
41. Yoshimura R, Watanabe Y, Kasai S, Wada S, Ohyama A, Hase T, Nakatani T, Chargui J, Touraine JL, Nakamura T: Hepatocyte growth factor (HGF) as a rapid diagnostic marker and its potential in the prevention of acute renal rejection. Transpl Int 2002, 15:156-162.
42. Rampino T, Gregorini M, Dal Canton A: Scatter factors in renal disease: Dr. Jeckyll and Mr. Hyde? Cytokine Growth Factor Rev 2009, 20:77-85.
43. Rampino T, Gregorini M, Bedino G, Piotti G, Gabanti E, Ibatici A, Sessarego N, Piacenza C, Balenzano CT, Esposito P, Bosio F, Soccio G, Frassoni F, Dal Canton A: Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors. Clin Sci (Lond) 2011, 120:25-36.
44. Zonta S, De Martino M, Bedino G, Piotti G, Rampino T, Gregorini M, Frassoni F, Dal Canton A, Dionigi P, Alessiani M: Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial? Transplant Proc 2010, 42:1336-1340.
45. Mizuno S, Nakamura T: Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am J Pathol 2005, 166:1895-1905.
46. O'Garra A, Murphy K: T-cell subsets in autoimmunity. Curr Opin Immunol 1993, 5:880-886.
47. O'Garra A, Vieira P: Regulatory T cells and mechanisms of immune system control. Nat Med 2004, 10:801-805.
48. Carrion F, Nova E, Ruiz C, Diaz F, Inostroza C, Rojo D, Mönckeberg G, Figueroa FE: Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus 2010, 19:317-322.
49. Perico N, Casiraghi F, Introna M, Gotti E, Todeschini M, Cavinato RA, Capelli C, Rambaldi A, Cassis P, Rizzo P, Cortinovis M, Marasà M, Golay J, Noris M, Remuzzi G: Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin J Am Soc Nephrol 2011, 6:412-422.
50. Shen H, Goldstein DR: IL-6 and TNF-α synergistically inhibit allograft acceptance. J Am Soc Nephrol 2009, 20:1032-1040.
51. Nakagiri T, Inoue M, Minami M, Shintani Y, Okumura M: Immunology mini-review: the basics of T(H)17 and interleukin-6 in transplantation. Transplant Proc 2012, 44:1035-1040.
52. Nakamura T, Sakai K, Nakamura T, Matsumoto K: Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepatol 2011, 26(Suppl 1):188-202.
53. Vargas GA, Hoeflich A, Jehle PM: Hepatocyte growth factor in renal failure: promise and reality. Kidney Int 2000, 57:1426-1436.
54. Matsumoto K, Nakamura T: Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 2001, 59:2023-2038.
55. Okunishi K, Dohi M, Nakagome K, Tanaka R, Mizuno S, Matsumoto K, Miyazaki J, Nakamura T, Yamamoto K: A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol 2005, 175:4745-4753.
56. Rutella S, Bonanno G, Procoli A, Mariotti A, de Ritis DG, Curti A, Danese S, Pessina G, Pandolfi S, Natoni F, Di Febo A, Scambia G, Manfredini R, Salati S, Ferrari S, Pierelli L, Leone G, Lemoli RM: Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood 2006, 108:218-227.
57. Futamatsu H, Suzuki J, Mizuno S, Koga N, Adachi S, Kosuge H, Maejima Y, Hirao K, Nakamura T, Isobe M: Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ Res 2005, 96:823-830.
58. Yamaura K, Ito K, Tsukioka K, Wada Y, Makiuchi A, Sakaguchi M, Akashima T, Fujimori M, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Suzuki J, Amano J, Isobe M: Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy. Circulation 2004, 110:1650-1657.
59. Oku M, Okumi M, Shimizu A, Sahara H, Setoyama K, Nishimura H, Sada M, Scalea J, Ido A, Sachs DH, Tsubouchi H, Yamada K: Hepatocyte growth factor sustains T regulatory cells and prolongs the survival of kidney allografts in major histocompatibility complex-inbred CLAWN-miniature swine. Transplantation 2012, 93:148-155.
60. Du T, Zou X, Cheng J, Wu S, Zhong L, Ju G, Zhu J, Liu G, Zhu Y, Xia S: Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells. Stem Cell Res Ther 2013, 4:59.
61. Cowin AJ, Kallincos N, Hatzirodos N, Robertson JG, Pickering KJ, Couper J, Belford DA: Hepatocyte growth factor and macrophage-stimulating protein are upregulated during excisional wound repair in rats. Cell Tissue Res 2001, 306:239-250.
62. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y: 'Green mice' as a source of ubiquitous green cells. FEBS Lett 1997, 407:313-319.
63. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C: The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 2003, 14:33-43.